# Novo Nordisk's $1.1 Billion Sickle Cell Bet Cleared Its Phase 3 Test. The Hard Part Is Still Coming. - Date: 2026-04-20 - Category: Biotech & Life Sciences Novo Nordisk cleared a Phase 3 test for its sickle cell pill. Whether that matters commercially depends on what happens next in a market defined by $2 million gene therapies. ---